Evidence map›Paper›PMID 30359374›Full record

ArticlePloS one2018

Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.

Yukiko Ohara, Yuriko Ozeki, Yoshitaka Tateishi, Tsukasa Mashima, Fumio Arisaka, Yasuo Tsunaka, Yoshie Fujiwara, Akihito Nishiyama, Yutaka Yoshida, Kengo Kitadokoro and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Evaluation of cytokine profiles related toFrontiers in immunology · 2024
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Yukiko OharaDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.ORCID 0000-0002-9930-4041
Yuriko OzekiDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.
Yoshitaka TateishiDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.
Tsukasa MashimaGraduate School of Energy Science, Kyoto University, Gokasho, Uji, Kyoto, Japan.
Fumio ArisakaCollege of Bioresource Sciences, Nihon University, Fujisawa, Kanagawa, Japan.
Yasuo TsunakaGraduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Japan.
Yoshie FujiwaraInstitute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Yoshida-Honmachi, Sakyo-ku, Kyoto, Japan.
Akihito NishiyamaDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.
Yutaka YoshidaDepartment of Structural Pathology, Institute of Nephrology, Graduate School of Medicine, Niigata University, Niigata, Japan.
Kengo KitadokoroGraduate School of Science and Technology, Department of Biomolecular Engineering, Kyoto Institute of Technology, Matsugasakigosyokaido-cho, Sakyo-ku, Kyoto, Japan.
Haruka KobayashiDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.
Yukihiro KanekoDepartment of Bacteriology and Virology, Osaka-City University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-3439-6141
Ichiro NakagawaDepartment of Microbiology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan.
Ryoji MaekuraDepartment of Respiratory Medicine, National Hospital Organization Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka, Japan.
Saburo YamamotoCentral Laboratory, Japan BCG Laboratory, Kiyose-shi, Tokyo, Japan.
Masato KatahiraGraduate School of Energy Science, Kyoto University, Gokasho, Uji, Kyoto, Japan.
Sohkichi MatsumotoDepartment of Bacteriology, Niigata University School of Medicine, Niigata, Japan.
Niigata University · JPKyoto University · JPJapan BCG Laboratory · JPKyoto Institute of Technology · JPNihon University · JPOsaka City University · JPToneyama National Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis causes the highest mortality among all single infections. Asymptomatic tuberculosis, afflicting one third of the global human population, is the major source as 5-10% of asymptomatic cases develop active tuberculosis during their lifetime. Thus it is one of important issues to develop diagnostic tools for accurately detecting asymptomatic infection. Mycobacterial DNA-binding protein 1 (MDP1) is a major protein in persistent Mycobacterium tuberculosis and has potential for diagnostic use in detecting asymptomatic infection. However, a previous ELISA-based study revealed a specificity problem; IgGs against MDP1 were detected in both M. tuberculosis-infected and uninfected individuals. Although the tertiary structures of an antigen are known to influence antibody recognition, the MDP1 structural details have not yet been investigated. The N-terminal half of MDP1, homologous to bacterial histone-like protein HU, is predicted to be responsible for DNA-binding, while the C-terminal half is assumed as totally intrinsically disordered regions. To clarify the relationship between the MDP1 tertiary structure and IgG recognition, we refined the purification method, which allow us to obtain a recombinant protein with the predicted structure. Furthermore, we showed that an IgG-ELISA using MDP1 purified by our refined method is indeed useful in the detection of asymptomatic tuberculosis.

Indexed as

AdultAgedBacterial ProteinsBinding SitesCase-Control StudiesCircular DichroismDNA-Binding ProteinsFemaleHumansImmunoglobulin GMaleMiddle AgedModels, MolecularProtein BindingProtein MultimerizationProtein Structure, SecondaryBacterial ProteinsDNA-Binding ProteinsImmunoglobulin GMDP1 protein, Mycobacterium

Identifiers

PMID30359374
PMCPMC6201868
OpenAlexW2898298473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.